1321 - 1330 of 7939 Results
Title
Year
-
OPENTitle: Association of Plasma and Cerebrospinal Fluid Alzheimer Disease Biomarkers With Race and the Role of Genetic Ancestry, Vascular Comorbidities, and Neighborhood FactorsJournal Name: JAMA Network OpenPublisher: American Medical Association (AMA)Vol: 5Issue #: 10Start Page: e2235068End Page: e2235068Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1001/jamanetworkopen.2022.35068Best OA location URL: https://jamanetwork.com/journals/jamanetworkopen/articlepdf/2797044/hajjar_2022_oi_220997_1664303851.08078.pdfCitation Count: 30
-
OPENTitle: Lysosomal lipid alterations caused by glucocerebrosidase deficiency promote lysosomal dysfunction, chaperone-mediated-autophagy deficiency, and alpha-synuclein pathologyJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 8Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41531-022-00397-6Best OA location URL: https://www.nature.com/articles/s41531-022-00397-6.pdfCitation Count: 24
-
OPENTitle: neuromaps: structural and functional interpretation of brain mapsJournal Name: Nature MethodsPublisher: Springer Science and Business Media LLCVol: 19Issue #: 11Start Page: 1472End Page: 1479Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1038/s41592-022-01625-wBest OA location URL: https://www.nature.com/articles/s41592-022-01625-w.pdfCitation Count: 164
-
OPENTitle: Anionic lipid vesicles have differential effects on the aggregation of early onset-associated α-synuclein missense mutantsJournal Name: Journal of Biological ChemistryPublisher: Elsevier BVVol: 298Issue #: 12Start Page: 102565End Page: 102565Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.jbc.2022.102565Best OA location URL: http://www.jbc.org/article/S0021925822010092/pdfCitation Count: 3
- Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosis2022OPENTitle: Motor- and cognition-related safety of pimavanserin in patients with Parkinson's disease psychosisJournal Name: Frontiers in NeurologyPublisher: Frontiers Media SAVol: 13Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fneur.2022.919778Best OA location URL: https://www.frontiersin.org/articles/10.3389/fneur.2022.919778/pdfCitation Count: 4
- Recruitment and Retention in Remote Research: Learnings From a Large, Decentralized Real-world Study2022OPENTitle: Recruitment and Retention in Remote Research: Learnings From a Large, Decentralized Real-world StudyJournal Name: JMIR Formative ResearchPublisher: JMIR Publications Inc.Vol: 6Issue #: 11Start Page: e40765End Page: e40765Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.2196/40765Best OA location URL: https://jmir.org/api/download?alt_name=formative_v6i11e40765_app1.pdf&filename=cda272c3b0860a3c3018580d7ddb36f6.pdfCitation Count: 8
-
RESTRICTEDTitle: Assessment of Bioenergetic Deficits in Patients With Parkinson Disease and Progressive Supranuclear Palsy Using 31 P-MRSIJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 99Issue #: 24Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201288Citation Count: 7
-
RESTRICTEDTitle: Body Mass Index, Abdominal Adiposity, and Incidence of Parkinson Disease in French Women From the E3N Cohort StudyJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 100Issue #: 3Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1212/wnl.0000000000201468Citation Count: 7
-
RESTRICTEDTitle: Genetics in parkinson’s disease: From better disease understanding to machine learning based precision medicineJournal Name: Frontiers in Molecular MedicinePublisher: Frontiers Media SAVol: 2Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: RESTRICTEDLicense: cc-byDOI - Digital Object Identifier: 10.3389/fmmed.2022.933383Best OA location URL: https://www.frontiersin.org/articles/10.3389/fmmed.2022.933383/pdfCitation Count: 0
-
OPENTitle: Inhibitory synaptic loss drives network changes in multiple sclerosis: An ex vivo to in silico translational studyJournal Name: Multiple Sclerosis JournalPublisher: SAGE PublicationsVol: 28Issue #: 13Start Page: 2010End Page: 2019Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1177/13524585221125381Best OA location URL: https://doi.org/10.1177/13524585221125381Citation Count: 19